Evaluation of sorafenib for advanced hepatocellular carcinoma with low α-fetoprotein in arrival time parametric imaging using contrast-enhanced ultrasonography

PURPOSE: To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib for hepatocellular carcinoma (HCC). METHODS: Twenty-one advanced HCC patients with low α-fetoprotein (AFP) levels (≤35...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiozawa, Kazue, Watanabe, Manabu, Ikehara, Takashi, Shimizu, Ryo, Shinohara, Mie, Igarashi, Yoshinori, Sumino, Yasukiyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222904/
https://www.ncbi.nlm.nih.gov/pubmed/27837395
http://dx.doi.org/10.1007/s10396-016-0757-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222904/
https://www.ncbi.nlm.nih.gov/pubmed/27837395
http://dx.doi.org/10.1007/s10396-016-0757-2

Ejemplares similares